NYSE:STK

Columbia Seligman Premium Technology Growth Fund Stock News

etoro logo Buy STK
*Your capital is at risk
$57.57
-0.110 (-0.191%)
At Close: Jun 03, 2026
DENVER--(BUSINESS WIRE)--STK Steakhouse, the globally recognized steakhouse concept from The ONE Group Hospitality, Inc. (“The ONE Group” or the “Company”) (Nasdaq: STKS) has officially opened
BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a second-quarter distribution, pursuant to its managed distribution policy, in th
Columbia Seligman Premium Technology Growth Fund offers a dynamic tech-income blend, with active management and a current Buy rating for core tech-income portfolios. STK's portfolio is heavily tilted
The Columbia Seligman Premium Technology Growth Fund (STK) has outperformed other tech-heavy growth funds, including QQQ, in the recent bull run post-2013. STK offers a higher technology and communica
A $500,000 hybrid portfolio using STK, SCHG, and ETB can generate ~$25,000 in annual dividends while outperforming the S&P 500 since 2017. STK balances growth and income with AI-focused tech exposure
I highlight seven closed-end funds, or CEFs, with rising NAVs and increasing distributions over the past 10–15 years, spanning diverse asset classes. These CEFs—PEO, BDJ, BME, CSQ, UTF, STK, and G
BOSTON--(BUSINESS WIRE)--The Board of Directors (the Board) of Columbia Seligman Premium Technology Growth Fund, Inc. (the Fund) (NYSE: STK) today announced that the Fund's 16th Annual Meeting of Stoc
There's one critical takeaway for us as AI flits through the market, whacking sector after sector as it does:
MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has entered into a clinical trial collaboration and supply agreement with Mer
Columbia Seligman Premium Technology Growth Fund (NYSE: STK - Get Free Report) shares were up 0.6% on Wednesday. The stock traded as high as $41.06 and last traded at $40.65. Approximately 36,258 shar
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, today
BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a first-quarter distribution, pursuant to its managed distribution policy, in the

STK: Tax-Efficient Income From The Growth Of AI

04:11pm, Tuesday, 03'rd Feb 2026
Columbia Seligman Premium Technology Growth Fund remains a strong buy, trading at a rare 3.97% NAV discount despite robust 12-month total returns of 31.7%. STK offers a compelling 6.8% dividend yield,
Columbia Seligman Premium Technology Growth Fund (STK) offers long-term capital appreciation and moderate income via a tech-focused, buy-write strategy with dynamic overwrite exposure. STK has deliver
BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a fourth quarter distribution, that is beyond its typical quarterly managed distr
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE